• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食物和体位对硝苯地平双相释放制剂药代动力学的影响。

The effects of food and posture on the pharmacokinetics of a biphasic release preparation of nifedipine.

作者信息

Challenor V, Waller D G, Gruchy B S, Renwick A G, George C F, McMurdo E T, McEwen J

出版信息

Br J Clin Pharmacol. 1986 Nov;22(5):565-70. doi: 10.1111/j.1365-2125.1986.tb02936.x.

DOI:10.1111/j.1365-2125.1986.tb02936.x
PMID:3790403
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1401174/
Abstract

The pharmacokinetics of a novel 20 mg biphasic release tablet of nifedipine were compared with the conventional 10 mg capsule and 20 mg sustained release preparations in healthy volunteers. The influence of food and posture on the pharmacokinetics of the biphasic tablet were studied. In the fasting state, the time to peak concentration of nifedipine was not significantly different between the 20 mg biphasic and 20 mg sustained release tablets, but plasma concentrations were higher between 2 and 4 h after the biphasic tablet. The terminal elimination half-lives of the two formulations were similar. In subjects who fed prior to nifedipine administration there was no significant difference between either the peak plasma concentration or terminal half-life of the biphasic tablet and two 10 mg capsules of nifedipine. When the biphasic preparation was given after a standard breakfast, the time to peak plasma concentration was significantly longer and the terminal half-life shorter than when given in the fasting state. The dissolution characteristics of the biphasic tablet were influenced by prior administration of food to an extent which may be of clinical significance during twice daily administration.

摘要

在健康志愿者中,对一种新型20毫克硝苯地平双相释放片的药代动力学与传统10毫克胶囊及20毫克缓释制剂进行了比较。研究了食物和体位对双相片药代动力学的影响。在禁食状态下,20毫克双相片和20毫克缓释片的硝苯地平达峰时间无显著差异,但双相片给药后2至4小时的血浆浓度更高。两种制剂的末端消除半衰期相似。在硝苯地平给药前进食的受试者中,双相片的血浆峰浓度或末端半衰期与两粒10毫克硝苯地平胶囊之间均无显著差异。当双相制剂在标准早餐后服用时,血浆达峰时间显著延长,末端半衰期比禁食状态下给药时缩短。双相片的溶出特性在一定程度上受给药前食物的影响,这在每日两次给药时可能具有临床意义。

相似文献

1
The effects of food and posture on the pharmacokinetics of a biphasic release preparation of nifedipine.食物和体位对硝苯地平双相释放制剂药代动力学的影响。
Br J Clin Pharmacol. 1986 Nov;22(5):565-70. doi: 10.1111/j.1365-2125.1986.tb02936.x.
2
Pharmacokinetics and bioavailability of three different galenic nifedipine preparations.三种不同剂型硝苯地平制剂的药代动力学和生物利用度
Arzneimittelforschung. 1986 Feb;36(2):256-60.
3
[Bioavailability of new nifedipine preparations in man. 1. Pharmacokinetics of nifedipine in the form of sustained-release tablets].
Arzneimittelforschung. 1985;35(12):1840-2.
4
Pharmacokinetics of nifedipine derived from a new retard tablet formulation.新型缓释片剂剂型硝苯地平的药代动力学
Eur J Drug Metab Pharmacokinet. 1990 Oct-Dec;15(4):273-8. doi: 10.1007/BF03190215.
5
Bioavailability of nifedipine: a comparison between two preparations.硝苯地平的生物利用度:两种制剂的比较。
Biopharm Drug Dispos. 1984 Apr-Jun;5(2):109-15. doi: 10.1002/bdd.2510050204.
6
Nifedipine: kinetics and dynamics in healthy subjects.硝苯地平:健康受试者的动力学与动态变化
Clin Pharmacol Ther. 1984 Jun;35(6):742-9. doi: 10.1038/clpt.1984.105.
7
Pharmacokinetics and pharmacodynamics of conventional and slow release forms of nifedipine in essential hypertensive patients.
Tohoku J Exp Med. 1986 Apr;148(4):421-38. doi: 10.1620/tjem.148.421.
8
Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.随机试验中口服溶液与普通片的双氯芬酸钾的药代动力学差异:进食与禁食状态的影响。
Headache. 2015 Feb;55(2):265-75. doi: 10.1111/head.12483. Epub 2014 Dec 24.
9
Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.两种缓释制剂在健康成年人中口服后哌甲酯的药代动力学。
Clin Pharmacokinet. 2003;42(4):393-401. doi: 10.2165/00003088-200342040-00007.
10
Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.两种市售硝苯地平缓释制剂的比较:一项探索性临床食物相互作用研究。
Clin Ther. 2008 Jan;30(1):48-58. doi: 10.1016/j.clinthera.2008.01.001.

引用本文的文献

1
Influence of posture on pharmacokinetics.姿势对药代动力学的影响。
Eur J Clin Pharmacol. 2009 Feb;65(2):109-19. doi: 10.1007/s00228-008-0579-2. Epub 2008 Oct 21.
2
The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties.硝苯地平胃肠道治疗系统(GITS)。药物、药代动力学和药理学特性评估。
Clin Pharmacokinet. 1996 Jan;30(1):28-51. doi: 10.2165/00003088-199630010-00003.
3
The influence of nutrition on the systemic availability of drugs. Part I: Drug absorption.营养对药物全身可利用性的影响。第一部分:药物吸收。
Klin Wochenschr. 1987 Oct 1;65(19):927-35. doi: 10.1007/BF01745506.
4
The pharmacokinetics of oral nifedipine--a population study.口服硝苯地平的药代动力学——一项群体研究。
Br J Clin Pharmacol. 1988 Jun;25(6):701-8. doi: 10.1111/j.1365-2125.1988.tb05256.x.
5
The influence of food on the pharmacokinetics of 'biphasic' nifedipine at steady state in normal subjects.食物对正常受试者稳态下“双相”硝苯地平药代动力学的影响。
Br J Clin Pharmacol. 1989 Nov;28(5):612-5. doi: 10.1111/j.1365-2125.1989.tb03551.x.
6
Beta-adrenoceptor antagonists plus nifedipine in the treatment of chronic stable angina pectoris.
Cardiovasc Drugs Ther. 1989 Jun;3 Suppl 1:275-85. doi: 10.1007/BF00148472.
7
Slow release nifedipine plus atenolol in chronic stable angina pectoris.缓释硝苯地平联合阿替洛尔治疗慢性稳定型心绞痛
Br J Clin Pharmacol. 1989 Nov;28(5):509-16. doi: 10.1111/j.1365-2125.1989.tb03536.x.
8
The combination of slow-release nifedipine and atenolol for stable angina.
Cardiovasc Drugs Ther. 1990 Aug;4 Suppl 5:899-904. doi: 10.1007/BF02018289.
9
Novel drug delivery systems. An overview of their impact on clinical pharmacokinetic studies.新型药物递送系统。其对临床药代动力学研究影响的概述。
Clin Pharmacokinet. 1991 Jan;20(1):1-14. doi: 10.2165/00003088-199120010-00001.
10
Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders.硝苯地平缓释制剂。对其在高血压、缺血性心脏病和周围血管疾病治疗中的当前用途及未来作用的评估。
Drugs. 1991 May;41(5):737-79. doi: 10.2165/00003495-199141050-00006.

本文引用的文献

1
Acute and long-term hypotensive effects and plasma concentrations of nifedipine in patients with essential hypertension.硝苯地平对原发性高血压患者的急性和长期降压作用及血浆浓度
Eur J Clin Pharmacol. 1982;23(3):197-201. doi: 10.1007/BF00547553.
2
Antihypertensive effect of fractionated sublingual administration of nifedipine in moderate essential hypertension.
Eur J Clin Pharmacol. 1980;17(3):161-4. doi: 10.1007/BF00561894.
3
Nifedipine tablets for hypertension: a study using continuous ambulatory intra-arterial recording.硝苯地平片治疗高血压:一项使用连续动态动脉内记录的研究。
Postgrad Med J. 1983;59 Suppl 2:95-7.
4
Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects.硝苯地平在正常受试者单次静脉注射和口服后的动力学及生物利用度。
J Clin Pharmacol. 1983 Apr;23(4):161-70. doi: 10.1002/j.1552-4604.1983.tb02720.x.
5
Acute antihypertensive effect and pharmacokinetics of a tablet preparation of nifedipine.
Eur J Clin Pharmacol. 1983;24(2):145-50. doi: 10.1007/BF00613808.
6
Interim report of multicenter double-blind, placebo-controlled studies of nifedipine in chronic stable angina.硝苯地平治疗慢性稳定型心绞痛多中心双盲安慰剂对照研究的中期报告
Am J Med. 1981 Oct;71(4):645-57. doi: 10.1016/0002-9343(81)90229-1.
7
Objective assessment of antianginal treatment: a double-blind comparison of propranolol, nifedipine, and their combination.抗心绞痛治疗的客观评估:普萘洛尔、硝苯地平及其联合用药的双盲比较。
Br Med J. 1980 Jul 19;281(6234):184-7. doi: 10.1136/bmj.281.6234.184.
8
Haemodynamic effects of nifedipine in essential hypertension at rest and during exercise.硝苯地平对原发性高血压患者静息及运动时的血流动力学影响。
J Hypertens. 1983 Aug;1(2):159-63. doi: 10.1097/00004872-198308000-00008.
9
[Anti-ischemic effect of nifedipine in delayed-action form. Results of a double-blind, randomized, crossover, placebo-controlled acute study].硝苯地平迟释剂型的抗缺血作用。一项双盲、随机、交叉、安慰剂对照急性研究的结果
Herz. 1983 Aug;8(4):206-10.
10
The first pass metabolism of nifedipine in man.硝苯地平在人体中的首过代谢。
Br J Clin Pharmacol. 1984 Dec;18(6):951-4. doi: 10.1111/j.1365-2125.1984.tb02569.x.